Shanda Group has entered a period of renewed visibility, with a series of incubated ventures coming to light over the past several months. At the center of this momentum is its founder, Tianqiao Chen, ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...

Recursion Pharmaceuticals, Inc. upgraded to Buy on promising REC-4881 data, strong partnerships, and AI-driven drug discovery ...

Recursion Pharmaceuticals (RXRX) stock rises after J.P. Morgan upgraded the biotech, citing a $1B+ sales potential for the ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...

C compiler, LustreC, into a generator of both executable code and associated specification. Model-based design tools are ...

Long-distance can be tough on any couple, but a gift can help bridge the gap, whether it's for a special occasion or simply a reminder that you're thinking of your significant other. We've rounded up ...

The relationship between cognition and emotion has fascinated Western philosophers for centuries. It is not surprising that much of that attraction has permeated brain science in general. Early ...

Kylie Jenner and Travis Scott end their on-again, off-again relationship in early January. (Meaning she’s fully single heading into 2023.) A source at the time tells Us Weekly, “Kylie and Travis are ...